FDA Approved Products

553 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:All NDA BLA ANDA

Lifecycle:Growth Peak LOE Approaching Post-LOE Launch Pre-Launch

Sort:Approval Date Name Competitive Pressure↓

Active:Lifecycle: Pre-LaunchClear all

chlorpheniramine maleate

ORAL · CAPSULE, EXTENDED RELEASE

trimeprazine tartrate

potassium chloride

ORAL · TABLET, EXTENDED RELEASE

trisulfapyrimidines (sulfadiazine; sulfamerazine; sulfamethazine)

Bristol Myers Squibb

ORAL · SUSPENSION

oxytetracycline

niacinamide; pyridoxine hydrochloride; tyrosine

ORAL · SUSPENSION

TPN ELECTROLYTES IN PLASTIC CONTAINER

calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride

INJECTION · INJECTABLE

hydrochlorothiazide; labetalol hydrochloride

oxprenolol hydrochloride

ORAL · CAPSULE

TRAVAMULSION 20%

INJECTION · INJECTABLE

TRAVERT 10% IN PLASTIC CONTAINER

INJECTION · INJECTABLE

methixene hydrochloride

chlorpheniramine maleate; phenylpropanolamine hydrochloride

ORAL · TABLET, EXTENDED RELEASE

triclofos sodium

triclofos sodium

ORAL · SOLUTION

ORAL · TABLET, EXTENDED RELEASE

ranitidine bismuth citrate

hexachlorophene

TOPICAL · EMULSION

hexachlorophene

TOPICAL · AEROSOL

ceruletide diethylamine

INJECTION · INJECTABLE

chlophedianol hydrochloride

doxylamine succinate

ORAL · CAPSULE

cryptenamine acetates

INJECTION · INJECTABLE

← PreviousPage 22 of 24Next →